SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA, a leading global provider of pharmaceutical packaging solutions, is headquartered in Germany. Established in 1884, the company has evolved into a key player in the pharmaceutical and healthcare industries, with significant operations across Europe, North America, and Asia. Specialising in high-quality glass and polymer packaging, SCHOTT Pharma offers a diverse range of products, including vials, syringes, and ampoules, designed to ensure the safety and efficacy of medications. Their commitment to innovation and sustainability sets them apart in a competitive market. With a strong focus on customer-centric solutions, SCHOTT Pharma has achieved notable milestones, including advancements in drug delivery systems and a robust portfolio that caters to the evolving needs of the pharmaceutical sector. Their reputation for excellence positions them as a trusted partner for pharmaceutical companies worldwide.
DitchCarbon Score
How does SCHOTT Pharma AG & Co. KGaA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Glass Products industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
SCHOTT Pharma AG & Co. KGaA's score of 49 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
SCHOTT Pharma AG & Co. KGaA's reported carbon emissions
In 2024, SCHOTT Pharma AG & Co. KGaA reported total carbon emissions of approximately 27536000 kg CO2e for Scope 1, 43941000 kg CO2e for Scope 2 (location-based), and a significant 398000000 kg CO2e for Scope 3 emissions. The Scope 3 emissions breakdown includes 30000000 kg CO2e from investments, 48000000 kg CO2e from capital goods, and 212000000 kg CO2e from purchased goods and services. For 2023, the company recorded emissions of about 30226000 kg CO2e for Scope 1, 43587000 kg CO2e for Scope 2 (location-based), and 418000000 kg CO2e for Scope 3. The Scope 3 emissions included 25000000 kg CO2e from investments and 227000000 kg CO2e from purchased goods and services. SCHOTT Pharma has set ambitious targets to reduce its greenhouse gas emissions, aiming for a 46.2% absolute reduction in Scope 1 and Scope 2 emissions by 2030, starting from 2021. This commitment reflects the company's proactive approach to addressing climate change and aligns with industry standards for sustainability. The emissions data is cascaded from SCHOTT AG, the parent company, indicating a structured approach to environmental accountability across its subsidiaries.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 30,226,000 | 00,000,000 |
| Scope 2 | 43,587,000 | 00,000,000 |
| Scope 3 | 418,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
SCHOTT Pharma AG & Co. KGaA is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
